Abstract
The susceptibility to Fas-mediated apoptosis was evaluated in seven T-cell lines (two infected with HTLV-2, one with HTLV-1, and four HTLV-free) as well as in Jurkat cells transfected with a Tax-2 expressing vector. Fas-mediated apoptosis was significantly reduced in the HTLV-1- and HTLV-2-infected lines in comparison with the HTLV-free lines regardless of the surface expression of Fas antigen (which was no different in the infected and uninfected cells). Fas-mediated apoptosis was also significantly inhibited in Jurkat cells transfected with the Tax-2 expressing vector without any modification in Fas expression. There was significantly more antiapoptotic Bcl-x(L) mRNA and protein in the transfected than in the untransfected Jurkat T cells. In conclusion, our results suggest that HTLV-2 is capable of inhibiting Fas-mediated apoptosis by means of a mechanism involving the tax-2 gene and probably the expression of bcl-x(L) messenger and protein.
Copyright 2001 Academic Press.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies / immunology
-
Antibodies / pharmacology
-
Apoptosis* / drug effects
-
Blotting, Western
-
Cells, Cultured
-
Culture Media, Conditioned / pharmacology
-
Gene Products, tax / genetics
-
Gene Products, tax / metabolism*
-
Gene Products, tax / pharmacology
-
HTLV-II Infections / pathology
-
HTLV-II Infections / virology
-
Human T-lymphotropic virus 1 / genetics
-
Human T-lymphotropic virus 1 / physiology
-
Human T-lymphotropic virus 2 / genetics
-
Human T-lymphotropic virus 2 / physiology*
-
Humans
-
In Situ Nick-End Labeling
-
Jurkat Cells
-
Proto-Oncogene Proteins / genetics
-
Proto-Oncogene Proteins / metabolism
-
Proto-Oncogene Proteins c-bcl-2 / genetics
-
Proto-Oncogene Proteins c-bcl-2 / metabolism
-
RNA, Messenger / genetics
-
RNA, Messenger / metabolism
-
T-Lymphocytes / drug effects
-
T-Lymphocytes / metabolism
-
T-Lymphocytes / pathology*
-
T-Lymphocytes / virology*
-
Transfection
-
bcl-2-Associated X Protein
-
bcl-X Protein
-
fas Receptor / analysis
-
fas Receptor / immunology
-
fas Receptor / physiology*
Substances
-
Antibodies
-
BCL2L1 protein, human
-
Culture Media, Conditioned
-
Gene Products, tax
-
Proto-Oncogene Proteins
-
Proto-Oncogene Proteins c-bcl-2
-
RNA, Messenger
-
bcl-2-Associated X Protein
-
bcl-X Protein
-
fas Receptor